Home/Filings/4/0001595585-20-000068
4//SEC Filing

Otto Dawn Parsell 4

Accession 0001595585-20-000068

CIK 0001595585other

Filed

May 11, 8:00 PM ET

Accepted

May 12, 8:38 PM ET

Size

23.9 KB

Accession

0001595585-20-000068

Insider Transaction Report

Form 4
Period: 2020-05-08
Otto Dawn Parsell
Sr VP, Clinical Development
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-05-08210420 total
    Exercise: $1.68Exp: 2026-09-26Common Stock (210 underlying)
  • Sale

    Common Stock

    2020-05-08$31.98/sh210$6,716255 total
  • Sale

    Common Stock

    2020-05-08$31.98/sh830$26,543255 total
  • Exercise/Conversion

    Common Stock

    2020-05-08$7.49/sh+523$3,917778 total
  • Exercise/Conversion

    Common Stock

    2020-05-08$1.68/sh+830$1,3941,085 total
  • Sale

    Common Stock

    2020-05-08$31.98/sh523$16,726255 total
  • Exercise/Conversion

    Common Stock

    2020-05-08$2.39/sh+1,437$3,4341,692 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-05-088304,190 total
    Exercise: $1.68Exp: 2026-11-02Common Stock (830 underlying)
  • Exercise/Conversion

    Common Stock

    2020-05-08$1.68/sh+210$353465 total
  • Sale

    Common Stock

    2020-05-08$31.98/sh1,437$45,955255 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-05-0852323,033 total
    Exercise: $7.49Exp: 2028-03-14Common Stock (523 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-05-081,43715,386 total
    Exercise: $2.39Exp: 2027-09-13Common Stock (1,437 underlying)
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2019.
  • [F2]This option vested 25% on June 8, 2017, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.
  • [F3]This option vested 25% on October 1, 2017, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.
  • [F4]This option vests 25% on March 15, 2019, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.
  • [F5]This option vests 25% on September 1, 2018, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.

Issuer

Tricida, Inc.

CIK 0001595585

Entity typeother

Related Parties

1
  • filerCIK 0001748808

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 8:38 PM ET
Size
23.9 KB